Time after Synthesis and Time after Injection Do Not Affect Diagnostic Quality of [(18)F]F-PSMA 1007 PET

por Relt, Elisabeth, Roll, Wolfgang, Claesener, Michael, Bögemann, Martin, Weckesser, Matthias, Rahbar, Kambiz
Publicado 2022

Incremental diagnostic value of [(18)F]tetrafluoroborate PET-CT compared to [(131)I]iodine scintigraphy in recurrent differentiated thyroid cancer

por Dittmann, Matthias, Gonzalez Carvalho, José Manuel, Rahbar, Kambiz, Schäfers, Michael, Claesener, Michael, Riemann, Burkhard, Seifert, Robert
Publicado 2020

Early side effects and first results of radioligand therapy with (177)Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study

por Ahmadzadehfar, Hojjat, Rahbar, Kambiz, Kürpig, Stefan, Bögemann, Martin, Claesener, Michael, Eppard, Elisabeth, Gärtner, Florian, Rogenhofer, Sebastian, Schäfers, Michael, Essler, Markus
Publicado 2015